The relationship between vitamin D (25-OH) and menopause is multifaceted. During menopause, estrogen levels decline, which may impair vitamin D metabolism. Estrogen enhances the conversion of 25-hydroxyvitamin D to its active form (1,25-dihydroxyvitamin D) in the kidneys. Lower estrogen could thus reduce active vitamin D availability even if 25-OH levels appear normal. Additionally, menopause increases osteoporosis risk, and adequate vitamin D is critical for calcium absorption and bone density. Observational studies suggest that postmenopausal women are more prone to vitamin D deficiency, which is linked to bone loss, muscle weakness, and possibly mood disturbances. However, evidence for a causal effect of vitamin D supplementation on menopausal symptoms (e.g., hot flashes) is limited; most data are observational or from small trials. A 25-OH vitamin D test can help identify deficiency, especially in those with limited sun exposure or darker skin. Supplementation should be guided by a healthcare provider to avoid toxicity (hypercalcemia). Overall, the association is moderate but not strongly causal, and individual responses vary.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f9f8bcb8ec83e415bf6d9430